Stay updated with breaking news from Parse Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall ...
Company to commercialize and create single-cell multi-omics products Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The Seattle-based company is planning to scale up the commercialization of its single-cell, whole-transcriptome assays and expand its product portfolio.
The Seattle-based company is planning to scale up the commercialization of its single-cell, whole-transcriptome assays and expand its product portfolio.